News Overview

Indian markets ended in the green as Nifty crossed 24,000, supported by pharma and IT strength, key stock moves in Sun Pharma, Reliance, and Jio Financial, and optimism from the India–New Zealand FTA boosting trade prospects.

India and New Zealand have signed a major Free Trade Agreement on 27 April 2026, aiming to enhance bilateral trade, investment flows, and services mobility. The deal provides significant tariff reductions, improved market access, and expanded opportunities across textiles, pharmaceuticals, IT, agriculture, and skilled workforce movement, marking a new phase in economic cooperation between the two countries.

Shares of Tanla Platforms surged 20% as investors turn optimistic on the back of strong Q4 results and dividend annoucement by the company

DP World Ltd has picked up a 49% stake in Reliance Industries’ upcoming multimodal logistics park at Mappedu near Chennai, according to sources. The JV, Chennai Global Logistics Park Ltd, has appointed Ajay Moghe as CEO. The project is part of the Bharatmala Pariyojana initiative, with official announcements on the deal still awaited.

Suzlon Energy continues its strong rally supported by fresh PSU wind energy orders, improving financials, and India’s renewable energy push. The stock shows bullish technical momentum but remains near overbought levels, making both growth potential and short-term caution important for investors.

India’s energy sector is witnessing a strong rally as geopolitical tensions in West Asia push crude and LPG prices higher. Stocks like ONGC, BPCL, and HPCL are gaining on expectations of improved pricing power, better revenue realization, and upcoming LPG policy reforms. While consumers face rising fuel costs, oil marketing and upstream companies are benefiting from tighter global supply and structural efficiency improvements in India’s energy distribution system.

Cohance Lifesciences has appointed Umang Vohra as Executive Chairman and Group CEO, marking a major leadership transition aimed at accelerating growth, strengthening global operations, and transforming the company into a leading CDMO platform.

Paytm shares fell after RBI cancelled its payments bank licence, citing compliance and governance issues. While the move hit sentiment, analysts believe Paytm’s core fintech business remains resilient with limited long-term impact.

Sun Pharmaceutical Industries is set to acquire Organon & Co. in a $11.75 billion all-cash deal, driving its stock up 7% on the NSE. The acquisition enhances its global footprint, strengthens its women’s health portfolio, and marks a major entry into biosimilars.

Markets ended lower for the third straight session with pressure from IT stocks, crude oil surge, and FII selling. Investors now track Q4 earnings, global cues, and key Nifty levels for direction.